Cargando…
Artificial intelligence for predicting five-year survival in stage IV metastatic breast cancer patients: A focus on sarcopenia and other host factors
We developed an artificial intelligence (AI) model that can predict five-year survival in patients with stage IV metastatic breast cancer, mainly based on host factors and sarcopenia. From a prospectively built breast cancer registry, a total of 210 metastatic breast cancer patients were selected in...
Autores principales: | Jang, Woocheol, Jeong, Changwon, Kwon, KyungA, Yoon, Tae In, Yi, Onvox, Kim, Kyung Won, Yang, Seoung-Oh, Lee, Jinseok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551304/ https://www.ncbi.nlm.nih.gov/pubmed/36237521 http://dx.doi.org/10.3389/fphys.2022.977189 |
Ejemplares similares
-
Artificial‐intelligence‐driven discovery of prognostic biomarker for sarcopenia
por: Chung, Heewon, et al.
Publicado: (2021) -
Gender Bias in Artificial Intelligence: Severity Prediction at an Early Stage of COVID-19
por: Chung, Heewon, et al.
Publicado: (2021) -
Detection of sarcopenia using deep learning-based artificial intelligence body part measure system (AIBMS)
por: Gu, Shangzhi, et al.
Publicado: (2023) -
Editorial: Artificial intelligence in human physiology
por: Ong, Chin Siang, et al.
Publicado: (2022) -
Editorial: Artificial intelligence in bioimaging and signal processing
por: Park, Seongyong, et al.
Publicado: (2023)